Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cell Death Differ ; 31(2): 159-169, 2024 02.
Artículo en Inglés | MEDLINE | ID: mdl-38110554

RESUMEN

Transcriptional activation of target genes is essential for TP53-mediated tumour suppression, though the roles of the diverse TP53-activated target genes in tumour suppression remains poorly understood. Knockdown of ZMAT3, an RNA-binding zinc-finger protein involved in regulating alternative splicing, in haematopoietic cells by shRNA caused leukaemia only with the concomitant absence of the PUMA and p21, the critical effectors of TRP53-mediated apoptosis and cell cycle arrest respectively. We were interested to further investigate the role of ZMAT3 in tumour suppression beyond the haematopoietic system. Therefore, we generated Zmat3 knockout and compound gene knockout mice, lacking Zmat3 and p21, Zmat3 and Puma or all three genes. Puma-/-p21-/-Zmat3-/- triple knockout mice developed tumours at a significantly higher frequency compared to wild-type, Puma-/-Zmat3-/- or p21-/-Zmat3-/-deficient mice. Interestingly, we observed that the triple knockout and Puma-/-Zmat3-/- double deficient animals succumbed to lymphoma, while p21-/-Zmat3-/- animals developed mainly solid cancers. This analysis suggests that in addition to ZMAT3 loss, additional TRP53-regulated processes must be disabled simultaneously for TRP53-mediated tumour suppression to fail. Our findings reveal that the absence of different TRP53 regulated tumour suppressive processes changes the tumour spectrum, indicating that different TRP53 tumour suppressive pathways are more critical in different tissues.


Asunto(s)
Neoplasias , Proteína p53 Supresora de Tumor , Animales , Ratones , Apoptosis/genética , Proteínas Reguladoras de la Apoptosis/genética , Proteínas Reguladoras de la Apoptosis/metabolismo , Incidencia , Ratones Noqueados , Neoplasias/genética , Proteína p53 Supresora de Tumor/metabolismo , Proteínas Supresoras de Tumor/genética , Proteínas Supresoras de Tumor/metabolismo
2.
PLoS One ; 13(7): e0200540, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30001419

RESUMEN

Major histocompatibility complex class II (MHC II) expression and turn-over are regulated via its ubiquitination by the membrane associated RING-CH 1 (MARCH1) E3 ligase. Unexpectedly, we show that MHC II ubiquitination also impacts MHC I. Lack of MARCH1 in B cells and dendritic cells (DCs) resulted in a significant reduction in surface MHC I expression. This decrease was not directly caused by changes in MARCH1 ubiquitination of MHC I but indirectly by altered MHC II trafficking in the absence of its ubiquitination. Deletion of MHC II in March1-/- cells restored normal MHC I surface expression and replacement of wild type MHC II by a variant that could not be ubiquitinated caused a reduction in MHC I expression. Furthermore, these cells displayed inefficient presentation of peptide and protein antigen via MHC I to CD8+ T cells. In summary, we describe an unexpected intersection between MHC I and MHC II such that the surface expression of both molecules are indirectly and directly regulated by MARCH1 ubiquitination, respectively.


Asunto(s)
Presentación de Antígeno/fisiología , Linfocitos B/inmunología , Linfocitos T CD8-positivos/inmunología , Células Dendríticas/inmunología , Antígenos de Histocompatibilidad Clase II/inmunología , Antígenos de Histocompatibilidad Clase I/inmunología , Ubiquitina-Proteína Ligasas/inmunología , Ubiquitinación/inmunología , Animales , Linfocitos B/citología , Linfocitos T CD8-positivos/citología , Línea Celular , Células Dendríticas/citología , Eliminación de Gen , Regulación de la Expresión Génica/inmunología , Antígenos de Histocompatibilidad Clase I/genética , Antígenos de Histocompatibilidad Clase II/genética , Ratones , Ratones Noqueados , Ubiquitina-Proteína Ligasas/genética , Ubiquitinación/genética
3.
Transfusion ; 55(1): 108-14, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25039791

RESUMEN

BACKGROUND: Extended room temperature (RT) hold of whole blood (WB) may affect the quality of red blood cell (RBC) components produced from these donations. The availability of better RBC additive solutions (ASs) may help reduce the effects. A new AS, AS-7 (SOLX, Haemonetics Corporation), was investigated for improved in vitro quality of RBCs prepared from WB held overnight at RT. STUDY DESIGN AND METHODS: Sixteen WB units were held for 21.4 hours ± 40 minutes at 22°C on cooling plates before processing. Each pair of ABO-matched WB units were pooled, divided into a WB filter pack containing saline-adenine-glucose-mannitol (control) and a LEUKOSEP WB-filter pack containing SOLX, and processed according to manufacturer's instructions. RBCs were stored at 2 to 6°C and sampled weekly until expiry. Glycophorin A (GPA+) and annexin V-binding microparticles (MPs) were quantitated using flow cytometry. Osmotic fragility, intracellular pH (pHi), adenosine triphosphate (ATP), 2,3-diphosphoglycerate (2,3-DPG), and routine quality variables were measured. Adhesion of RBCs to human endothelial cells (ECs) was evaluated by flow perfusion under low shear stress (0.5 dyne/cm(2) ), similar to low blood flow in microvessels. RESULTS: ATP and 2,3-DPG levels were improved for SOLX-RBCs. SOLX-RBCs maintained higher pHi, increased resistance to hypotonic stress, and reduced numbers of GPA+ MPs. No significant difference was observed between annexin V binding to MPs or adhesion of RBCs to ECs under shear stress. CONCLUSION: SOLX-stored RBCs showed increased osmotic resistance, pHi, and reduced GPA+ MPs and together with higher ATP and 2,3-DPG levels demonstrated improved in vitro RBC quality measures during 42 days of storage.


Asunto(s)
Conservación de la Sangre/métodos , Eritrocitos/efectos de los fármacos , Soluciones Preservantes de Órganos/farmacología , 2,3-Difosfoglicerato/sangre , Adenosina Trifosfato/sangre , Anexina A5/metabolismo , Adhesión Celular/efectos de los fármacos , Micropartículas Derivadas de Células/efectos de los fármacos , Micropartículas Derivadas de Células/metabolismo , Eritrocitos/citología , Glicoforinas/metabolismo , Hemorreología , Células Endoteliales de la Vena Umbilical Humana , Humanos , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Fragilidad Osmótica/efectos de los fármacos , Temperatura , Factores de Tiempo
4.
Transfusion ; 54(3): 560-8, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23869602

RESUMEN

BACKGROUND: Saline-adenine-glucose-mannitol (SAGM) and a variant solution, AS-1, have been used for more than 30 years to preserve red blood cells (RBCs). Reputedly these RBC components have similar quality, although no paired study has been reported. To determine whether differences exist, a paired study of SAGM RBCs and AS-1 RBCs was conducted to identify membrane changes, including microparticle (MP) quantitation and in vitro RBC-endothelial cell (EC) interaction. STUDY DESIGN AND METHODS: Two whole blood packs were pooled and split and RBCs were prepared (n=6 pairs). One pack was suspended in SAGM and one in AS-1. Samples were collected during 42 days of refrigerated storage. RBC shape and size and glycophorin A (GPA)(+) and phosphatidylserine (PS)(+) MPs were measured by flow cytometry. RBC adhesion to ECs was determined by an in vitro flow perfusion assay. Routine variables (pH, hemolysis) were also measured. RESULTS: Compared to SAGM RBCs, AS-1 RBCs had lower hemolysis (p<0.04), lower GPA(+) MPs (p<0.03), and lower PS(+) MPs (p<0.03) from Day 14 onward. AS-1 RBCs had higher (p<0.02) side scatter from Day 28 onward compared to SAGM RBCs. SAGM RBCs were more adherent to ECs on Day 28 of storage compared to AS-1 RBCs (p=0.04), but reversed on Day 42 (p=0.02). CONCLUSION: SAGM RBCs lose more membrane during storage. SAGM RBCs had increased adherence to ECs on Day 28 of storage, while AS-1 RBCs were more adherent on Day 42. The effect of these differences on the function and survival of SAGM RBCs and AS-1 RBCs after transfusion remains to be determined.


Asunto(s)
Adenina/farmacología , Conservación de la Sangre/métodos , Eritrocitos/efectos de los fármacos , Glucosa/farmacología , Manitol/farmacología , Adulto , Citometría de Flujo , Humanos , Persona de Mediana Edad , Adulto Joven
5.
Transfusion ; 47(6): 966-8, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17524084

RESUMEN

BACKGROUND: Membrane-associated carbohydrate changes act as signals for removal of senescent and damaged red blood cells (RBCs) from the circulation and could play a role in the RBC storage lesion and RBC survival after transfusion. In this study, a panel of lectins was used to investigate the expression of carbohydrates on RBCs that had been separated before storage into young and old RBCs. STUDY DESIGN AND METHODS: Leukodepleted RBCs were separated before storage into young and old RBCs (n = 9 paired units) by centrifugation and sampled at nominated time points during 42 days of storage. Changes to carbohydrate expression at the RBC membrane during storage were determined by flow cytometry with a panel of fluorescein-labeled lectins. RESULTS: Old RBCs showed lower fluorescence intensity throughout storage, suggesting reduced binding of lectins compared to young RBCs. Progressively increased binding of lectins specific for galactose and N-acetylglucosamine residues was observed during storage of young and old RBCs. CONCLUSION: Changes to lectin binding during storage of RBCs suggest that significant changes occur to the carbohydrate structures at the RBC membrane. These findings provide further insight into the mechanisms of the RBC storage lesion and potential influence on RBC survival after transfusion.


Asunto(s)
Acetilglucosamina/metabolismo , Senescencia Celular/fisiología , Membrana Eritrocítica/metabolismo , Galactosa/metabolismo , Lectinas/farmacología , Preservación Biológica , Eliminación de Componentes Sanguíneos , Supervivencia Celular , Transfusión de Eritrocitos , Humanos
6.
J Immunol Methods ; 322(1-2): 50-6, 2007 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-17346741

RESUMEN

Removal of senescent, damaged or diseased red blood cells (RBCs) from the circulation in vivo occurs by a process known as erythrophagocytosis. The exact details of the signaling mechanisms that mark RBCs for recognition and influence erythrophagocytosis are still not completely understood. The aim of this study was to develop a quantitative, fluorometric erythrophagocytosis assay for human RBCs and phagocytes to aid elucidation of the biological mechanisms regulating erythrophagocytosis. RBCs were labelled with the lipophilic fluorescent dye PKH26 and incubated with the human monocytic cell line THP-1 at 37 degrees C for 45 min. Non-phagocytosed RBCs were lysed with hypotonic saline. Phagocytosed PKH26-labelled RBCs within THP-1 cells were detected with a fluorescence plate-reader and quantitated using a standard curve of known numbers of PKH26-labelled RBCs. Assay conditions were optimised for the numbers of phagocytes and RBCs, incubation time and fluorescence excitation and emission wavelengths. Erythrophagocytosis was also assessed by flow cytometry to determine the proportion of THP-1 cells with ingested RBCs and showed good correlation (P=0.7) between the two methods. The quantitative, fluorometric plate assay is very sensitive and has good reproducibility, making it a useful tool to investigate the biological mechanisms that regulate erythrophagocytosis of normal and diseased RBCs.


Asunto(s)
Envejecimiento Eritrocítico/inmunología , Eritrocitos/inmunología , Citometría de Flujo/métodos , Colorantes Fluorescentes/química , Compuestos Orgánicos/química , Fagocitosis , Línea Celular , Humanos , Monocitos/inmunología
8.
Transfus Apher Sci ; 34(1): 15-23, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16377250

RESUMEN

The influence of the age of the red blood cell (RBC) within its 120-day lifecycle at the time of blood donation on the RBC storage lesion is not well understood. Expression of cell adhesion molecules (CAMs) (CD44, CD47, CD58 and CD147), glycophorin A (GPA) and phosphatidylserine (PS) on young and old RBCs density separated prior to storage of the RBC concentrate was determined by flow cytometry. Older RBCs showed significantly reduced expression of GPA throughout storage and CD44 and CD147 from Day 28 onwards compared to young RBCs. Storage in the presence of leukocytes caused a significant decline in the expression of CD44, CD58, CD147 and GPA, whereas RBCs that were pre-storage leukocyte depleted maintained a relatively consistent level of expression throughout storage. PS was not detected at the external RBC membrane of young or old RBCs during storage. Increased levels of annexin V were detected in the supernatant of RBCs stored in the presence of leukocytes, with significantly greater supernatant levels found for old RBCs compared to young RBCs. These findings provide new insight into the RBC storage lesion and indicate that RBC age at the time of donation impacts upon the quality of stored RBC concentrates.


Asunto(s)
Anexina A5/metabolismo , Conservación de la Sangre , Eritrocitos/citología , Eritrocitos/patología , Glicoforinas/metabolismo , Leucocitos/metabolismo , Envejecimiento , Basigina/biosíntesis , Antígenos CD58/biosíntesis , Adhesión Celular , Eritrocitos/metabolismo , Citometría de Flujo , Humanos , Receptores de Hialuranos/biosíntesis , Concentración de Iones de Hidrógeno , Fosfatidilserinas/metabolismo , Control de Calidad , Manejo de Especímenes , Tiempo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...